• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: Ethicon Inc. ETHICON; agent, absorbable hemostatic, non-collagen based

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

Ethicon Inc. ETHICON; agent, absorbable hemostatic, non-collagen based Back to Search Results
Catalog Number 3013SP
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Inflammation (1932); Rash (2033)
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that a patient underwent a total knee arthroplasty: tka procedure on (b)(6) 2026 and absorbable hemostat was used.About one week to ten days after the procedure a rash appeared extending from the knee to the ankle.Regarding the application site, it was used only on the posterior joint capsule and not on the soft tissue.Irrigation was also performed.The patient went to a dermatologist.Additional information was requested.
 
Additional Manufacturer Narrative
Product complaint # (b)(4).D4: udi: as the lot number for the device involved in the event was not provided, the full udi is currently not available.To date the device has not been returned.If the device or further details are received at a later date a supplemental medwatch will be sent.Additional information was requested, and the following was obtained: allergy medication was prescribed, and the inflammation is showing signs of improvement.Physician's comment: the patient had a metal allergy, so titanium plates were used on both sides.The only difference between this surgery and the previous one is the use of this product, so i believe there is a causal relationship with this product.Attempts are being made to obtain the following information.To date no response has been provided.If further details are received at a later date a supplemental medwatch will be sent.1.Please provide the following patient demographic information, if available: age, gender, weight, bmi at the time of index procedure? 2.What were the diagnosis and indication for the index surgical procedure? 3.Please provide any relevant patient history: patient pre-existing medical conditions (i.E.Allergies, history of reactions), all concomitant medications, past medical history, any treatment required for events, dose, frequency, and therapy dates.4.Was there any intraoperative concurrent use of other products? 5.What is the lot number? 6.What was the intended use of the surgicel? was it used to address active bleeding or used prophylactically? 7.Where was the surgicel used (on what tissue)? 8.How much surgicel was used during the procedure? 9.Was the surgicel product left in place? was the excess irrigated and removed? 10.What were current symptoms following the index surgical procedure? what was the onset date of the rash? 11.Has any surgical or medical intervention been performed? 12.If medication was required, please clarify if it was prescription strength.13.Was there an alleged deficiency of the surgicel that contributed to the patient¿s post-operative rash? 14.What is the patient¿s current status? 15.What is the users experience w/surgicel powder and other hemostatic agents? 16.Was a pneumatic tourniquet used during the procedure? if yes was it released prior to using the product.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon, or its employees that the report constitutes an admission that the product, ethicon, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ETHICON
Common Device Name
agent, absorbable hemostatic, non-collagen based
Manufacturer (Section D)
Ethicon Inc.
1000 route 202
raritan NJ 08869
Manufacturer (Section G)
Ethicon Inc.-San Lorenzo PR
road 183, km 8.3
san lorenzo PR 00754
PR   00754
Manufacturer Contact
orla o'mahony
1000 route 202
raritan, NJ 08869
+1(303)552-6892
MDR Report Key50946655
Report Number2210968-2026-09929
Device Sequence Number9552457
Product Code LMG
UDI-Device Identifier10705031237506
UDI-Public10705031237506
Combination Product (Y/N)N
Initial Reporter CountryJA
PMA/510(K) Number
N12159
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Health Professional
Type of Report Initial
Report Date (Section B) 09/30/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Catalogue Number3013SP
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 09/15/2026
Initial Report FDA Received Date09/30/2026
Was Device Evaluated by Manufacturer? (Y/N) No
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient SexUnknown
-
-